Other studies found that the slope of MSE at large scales was smaller in AD patients than in healthy controls [42,43] and might potentially predict the efficacy of acetylcholinesterase inhibitors for AD treatment [42]. The gene discussed is ACHE; the disease is Alzheimer disease.